Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

July 29, 2020 by Alan Khadavi

Newborns born to Covid-19 Mothers

Humans are susceptible to SARS-CoV-2 and pregnant women and newborns are potential at-risk groups for COVID-19.

Coronavirus infections in pregnant women can cause adverse consequences, such as spontaneous miscarriage, preterm delivery and intrauterine growth restriction and stillbirth. As of now, there is no evidence of mother to child vertical transmission of SARS-CoV-2, it is important to clarify whether the maternal inflammatory response affects the development and physiological state of newborns.

A study published in the Journal of Allergy and Clinical Immunology, July 2020, titled “The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China” examined the immune status of newborns from mothers with COVID-19 in the 3rd trimester. The following results were obtained from the study:

  • Under strict protective measures, 51 newborns born to SARS-CoV-2 infected mothers in the third trimester were not infected.
  • Mother’s infection had no significant effect on the cellular and humoral immunologic status of the newborn and lymphocyte differentiation was not affected significantly.
  • Third trimester pregnant women with mild to moderate COVID-19 gave birth to healthy babies.

The authors concluded that COVID-19 in the third trimester did not significantly affect the immunity of the fetus and there was no evidence that immune subsets was seriously unbalanced.

The authors note that a limitation of the study is that changes in the immune system were only monitored at birth and not afterwards. More studies will need to be done to see if there are any long term immune manifestations. They also conclude that because of the role of the placental barrier, the newborn is in a relatively closed environment in the uterus. After the birth of the newborn, immune cells are stimulated by external antigens, thus affecting their later differentiation.

More studies will need to be examined to see if there are any longer ramifications in newborns born to COVID-19 mothers.

CVID and Covid-19

 

Filed Under: Blog, Headlines

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page